StreetInsider.com News Articles

Form 4 TREACE MEDICAL CONCEPTS, For: Sep 30 Filed by: Elder Scot Michael

Fri, 02 Oct 2026 19:00:00 -0400

si-local-file:///var/storage/secattach/20261002/27143964.html

Treace reports 5-year Lapiplasty study data at AOFAS meeting

Thu, 17 Sep 2026 17:17:46 -0400

Treace Medical Concepts, Inc. (NASDAQ: TMCI) presented results from three clinical studies at the American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle, Washington, according to a company press release.

The ALIGN3D five-year Lapiplasty study, presented by Daniel Farber, MD, of Lehigh Valley Orthopedic Institute, included final analysis of 137 of 173 enrolled patients. The data showed an average return to weight bearing in a walking boot at 8.4 days, a radiographic recurrence rate of 0.8% using HVA greater than 20 degrees at five years, and clinically significant reductions in patient-reported outcome scores through five years.

The MTA3D Adductoplasty two-year interim

Treace reports 5-year Lapiplasty study data at AOFAS meeting

Thu, 17 Sep 2026 17:17:46 -0400

The MTA3D Adductoplasty two-year interim

Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

Thu, 17 Sep 2026 17:16:00 -0400

PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced the presentation of the results from three clinical studies at the American Orthopaedic Foot & Ankle Society (“AOFAS”) Annual Meeting in Seattle, Washington. The presentations include data on the milestone 5-year ALIGN3D® Lapiplasty®, the MTA3D® Adductoplasty® and the SPRINT™ SpeedPlate® clinical studies.

"We are proud to present a robust body of clinical evidence at

Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

Thu, 17 Sep 2026 17:16:00 -0400

"We are proud to present a robust body of clinical evidence at

Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting

Tue, 15 Sep 2026 17:06:00 -0400

PONTE VEDRA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced it will highlight multiple new product innovations and present clinical data at the American Orthopaedic Foot & Ankle Society (“AOFAS”) Annual Meeting in Seattle, Washington from September 16-19, 2026.

"We are excited to showcase our expanding portfolio of best-in-class foot & ankle innovations at AOFAS 2026," said John T. Treace, CEO, Founder and Chairman

Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting

Tue, 15 Sep 2026 17:06:00 -0400

"We are excited to showcase our expanding portfolio of best-in-class foot & ankle innovations at AOFAS 2026," said John T. Treace, CEO, Founder and Chairman

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 20 Filed by: Treace John T.

Mon, 24 Aug 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260824/26968938.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 20 Filed by: Treace John T.

Mon, 24 Aug 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260824/26968938.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:27:00 -0400

si-local-file:///var/storage/secattach/20260814/26926415.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:27:00 -0400

si-local-file:///var/storage/secattach/20260814/26926415.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Scanlan Sean F.

Wed, 12 Aug 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260812/26914577.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Scanlan Sean F.

Wed, 12 Aug 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260812/26914577.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: Treace John T.

Wed, 12 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260812/26914459.html

Form SCHEDULE 13G/A TREACE MEDICAL CONCEPTS, Filed by: Treace John T.

Wed, 12 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260812/26914459.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Elder Scot Michael

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914439.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Elder Scot Michael

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914439.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Hair Mark

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914444.html

Form 4 TREACE MEDICAL CONCEPTS, For: Aug 09 Filed by: Hair Mark

Wed, 12 Aug 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260812/26914444.html

Treace Medical Concepts Inc (TMCI) PT Raised to $5 at Truist Securities

Mon, 10 Aug 2026 07:23:05 -0400

Truist Securities analyst Richard Newitter raised the price target on Treace Medical Concepts Inc (NASDAQ: TMCI) to $5.00 (from $4.00) while maintaining a Hold rating.

Treace Medical Concepts, Inc. (TMCI) Tops Q2 EPS by 6c

Fri, 07 Aug 2026 07:31:45 -0400

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.4 million versus the consensus estimate of $43.94 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30

Fri, 07 Aug 2026 07:13:00 -0400

si-local-file:///var/storage/secattach/20260807/26887437.html

Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30

Fri, 07 Aug 2026 07:13:00 -0400

si-local-file:///var/storage/secattach/20260807/26887437.html

Form 8-K TREACE MEDICAL CONCEPTS, For: Aug 07

Fri, 07 Aug 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260807/26887432.html

Form 8-K TREACE MEDICAL CONCEPTS, For: Aug 07

Fri, 07 Aug 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260807/26887432.html